Samrat Pharma

{
  "main_header": {
    "sid": 116063,
    "name": "Samrat Pharma",
    "stock_name": "Samrat Pharma",
    "full_name": "Samrat Pharmachem Ltd",
    "name_url": "stocks-analysis/samrat-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "236.50",
    "chg": 2.4,
    "chgp": "1.03%",
    "dir": 1,
    "prev_price": "234.10",
    "mcapval": "77.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530125,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE103E01016",
    "curr_date": "Feb 13",
    "curr_time": "",
    "bse_nse_vol": "1.31 k",
    "exc_status": "Active",
    "traded_date": "Feb 13, 2026",
    "traded_date_str": "2026 02 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/samrat-pharma-116063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Samrat Pharmachem Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-samrat-pharmachem-ltd-fallingrising-3832008",
        "imagepath": "",
        "date": "2026-02-11 00:55:35",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Robust Short-Term Performance Drives Momentum</strong></p>\n<p>Samrat Pharmachem has demonstrated remarkable strength over the past week, delivering a gain of 17.82%, significantly outpacing the Sensex’s modest 0.64% rise during the same period. This surge is part of a broader positive trend, with the stock also posting a 10.47% increase over the last month and a 7.92% gain year-to-date, while the Sensex has declined by 1.11% in the same timeframe. Such relative outperformance highlights growing investor interest and confidence in the company’s near-term prospects.</p>\n<p>Today’s trading session further reinforced this momentum. The stock opened with a gap up of 4.69%, signalling strong buying interest from the outset. It reached an intraday high of ₹255.60, representing a 7.46% increase from..."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3830447",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SamratPharmache_mojoScore_3830447.png",
        "date": "2026-02-10 10:10:48",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd Valuation Shifts Signal Elevated Price Risk Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-valuation-shifts-signal-elevated-price-risk-amid-sector-challenges-3815211",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SamratPharmache_valuationdot_3815211.png",
        "date": "2026-02-02 08:00:15",
        "description": "Samrat Pharmachem Ltd’s valuation metrics have recently deteriorated, shifting from expensive to very expensive territory, raising concerns about its price attractiveness amid a challenging sector backdrop and subdued returns relative to benchmarks."
      },
      {
        "title": "Samrat Pharmachem Ltd Falls to 52-Week Low of Rs.195.1 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-falls-to-52-week-low-of-rs1951-amidst-continued-underperformance-3811614",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SamratPharmache_priceRelatedfactors_3811614.png",
        "date": "2026-01-30 14:15:11",
        "description": "Samrat Pharmachem Ltd’s stock touched a fresh 52-week low of Rs.195.1 today, marking a significant decline amid ongoing challenges in its financial performance and market positioning. This new low reflects a continuation of the stock’s downward trajectory over the past year, with the share price now trading well below all key moving averages."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3811143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SamratPharmache_mojoScore_3811143.png",
        "date": "2026-01-30 10:10:35",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd Stock Falls to 52-Week Low of Rs.199",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-stock-falls-to-52-week-low-of-rs199-3805898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SamratPharmache_priceRelatedfactors_3805898.png",
        "date": "2026-01-27 11:01:33",
        "description": "Samrat Pharmachem Ltd’s stock reached a fresh 52-week low of Rs.199 today, marking a significant decline amid ongoing challenges in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its sector peers and benchmark indices, reflecting persistent pressures on the company’s financial and market metrics."
      },
      {
        "title": "Samrat Pharmachem Ltd Stock Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3798385",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SamratPharmache_priceRelatedfactors_3798385.png",
        "date": "2026-01-21 10:49:52",
        "description": "Samrat Pharmachem Ltd’s stock declined to a fresh 52-week low of Rs.206 on 21 Jan 2026, marking a significant milestone in its ongoing downward trajectory. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and the broader market, reflecting persistent pressures on its financial and market performance."
      },
      {
        "title": "Samrat Pharmachem Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/samrat-pharmachem-ltd-is-rated-strong-sell-3794077",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SamratPharmache_mojoScore_3794077.png",
        "date": "2026-01-19 10:10:18",
        "description": "Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Samrat Pharmachem Ltd Falls to 52-Week Low of Rs.210 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/samrat-pharmachem-ltd-falls-to-52-week-low-of-rs210-amidst-continued-underperformance-3789957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SamratPharmache_priceRelatedfactors_3789957.png",
        "date": "2026-01-12 11:20:55",
        "description": "Samrat Pharmachem Ltd’s stock declined sharply to a fresh 52-week low of Rs.210 on 12 Jan 2026, marking a significant milestone in its ongoing downward trajectory. The pharmaceutical company’s shares have underperformed both the sector and broader market indices, reflecting persistent pressures on its financial and market performance."
      }
    ],
    "total": 5740,
    "sid": "116063",
    "stock_news_url": "https://www.marketsmojo.com/news/samrat-pharmachem-116063"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "12-Jan-2026",
      "details": "Certificate u/r 74(5) for the quarter ended 31/12/2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Dec-2025",
      "details": "The Trading Window of the Company shall remain closed from Thursday January 1 2026 till 48 hours after the declaration of Un-audited financial results for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended December 31 2025",
      "datetime": "29-Dec-2025",
      "details": "Samrat Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the un-audited financial results for the quarter ended December 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Samrat Pharmachem Ltd has declared <strong>10%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Samrat Pharmachem Ltd falling/rising?

2026-02-11 00:55:35

Robust Short-Term Performance Drives Momentum

Samrat Pharmachem has demonstrated remarkable strength over the past week, delivering a gain of 17.82%, significantly outpacing the Sensex’s modest 0.64% rise during the same period. This surge is part of a broader positive trend, with the stock also posting a 10.47% increase over the last month and a 7.92% gain year-to-date, while the Sensex has declined by 1.11% in the same timeframe. Such relative outperformance highlights growing investor interest and confidence in the company’s near-term prospects.

Today’s trading session further reinforced this momentum. The stock opened with a gap up of 4.69%, signalling strong buying interest from the outset. It reached an intraday high of ₹255.60, representing a 7.46% increase from...

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-02-10 10:10:48

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 February 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Samrat Pharmachem Ltd Valuation Shifts Signal Elevated Price Risk Amid Sector Challenges

2026-02-02 08:00:15

Samrat Pharmachem Ltd’s valuation metrics have recently deteriorated, shifting from expensive to very expensive territory, raising concerns about its price attractiveness amid a challenging sector backdrop and subdued returns relative to benchmarks.

Read full news article

Samrat Pharmachem Ltd Falls to 52-Week Low of Rs.195.1 Amidst Continued Underperformance

2026-01-30 14:15:11

Samrat Pharmachem Ltd’s stock touched a fresh 52-week low of Rs.195.1 today, marking a significant decline amid ongoing challenges in its financial performance and market positioning. This new low reflects a continuation of the stock’s downward trajectory over the past year, with the share price now trading well below all key moving averages.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-01-30 10:10:35

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Samrat Pharmachem Ltd Stock Falls to 52-Week Low of Rs.199

2026-01-27 11:01:33

Samrat Pharmachem Ltd’s stock reached a fresh 52-week low of Rs.199 today, marking a significant decline amid ongoing challenges in the Pharmaceuticals & Biotechnology sector. The stock has underperformed its sector peers and benchmark indices, reflecting persistent pressures on the company’s financial and market metrics.

Read full news article

Samrat Pharmachem Ltd Stock Hits 52-Week Low Amidst Continued Downtrend

2026-01-21 10:49:52

Samrat Pharmachem Ltd’s stock declined to a fresh 52-week low of Rs.206 on 21 Jan 2026, marking a significant milestone in its ongoing downward trajectory. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and the broader market, reflecting persistent pressures on its financial and market performance.

Read full news article

Samrat Pharmachem Ltd is Rated Strong Sell

2026-01-19 10:10:18

Samrat Pharmachem Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Samrat Pharmachem Ltd Falls to 52-Week Low of Rs.210 Amidst Continued Underperformance

2026-01-12 11:20:55

Samrat Pharmachem Ltd’s stock declined sharply to a fresh 52-week low of Rs.210 on 12 Jan 2026, marking a significant milestone in its ongoing downward trajectory. The pharmaceutical company’s shares have underperformed both the sector and broader market indices, reflecting persistent pressures on its financial and market performance.

Read full news article

View All News